PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-Jan-2024 MindBio Therapeutics Nears Completion of Landmark Phase 2a LSD Microdosing (MB22001) Clinical Trial in Depressed Patients AccessWire
30-Jan-2024 Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service Creative Enzymes
30-Jan-2024 Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability Creative Enzymes
30-Jan-2024 BioNxt Solutions Announces Closing of Final Tranche of Non-Brokered Private Placement AccessWire
30-Jan-2024 CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering AccessWire
29-Jan-2024 Pharma-Bio Serv Announces Full Year Results AccessWire
29-Jan-2024 FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates AccessWire
29-Jan-2024 Gedeon Richter becomes strategic investor of Formycon via equity investment Formycon AG
29-Jan-2024 Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor Formycon AG
29-Jan-2024 America's Best Dentist is Now Serving Fountain Valley in Cosmetic Dentistry as KYT Dental Services AccessWire
29-Jan-2024 MeVis publishes figures for financial year 2022/2023 and forecast for 2023/2024 MeVis Medical Solutions AG
29-Jan-2024 Fitbit and Quest Diagnostics Collaborate To Advance Research on the Use of Wearable Devices To Improve Metabolic Health AccessWire
29-Jan-2024 LightWork Therapy & Recovery Expands Services With Evening Outpatient Programs for Women AccessWire
29-Jan-2024 Boom in life science recruitment leads to ARx expansion plans ARx
29-Jan-2024 Specialty-Driven Platforms Outperform Broad-Spectrum EHRs in Top 2024 Physician Satisfaction Ratings, 14th Annual Black Book Ambulatory Practice Surveys AccessWire
29-Jan-2024 Aurora Behavioral Health Announces Executive Leadership Promotions AccessWire
29-Jan-2024 The Wall Street Journal Names Merck Among Top 10 Best-Managed Companies AccessWire
29-Jan-2024 Jaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference AccessWire
29-Jan-2024 Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update AccessWire
29-Jan-2024 Protagonist Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2024 AccessWire